Pravin Dugel

Insider Reports History

Location
C/O Aerpio Pharmaceuticals, Inc., 9987 Carver Road, Cincinnati, OH
Signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pravin Dugel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Executive Chairman, President and CEO, Director Common Stock 3.16M $38M $12.04 Nov 24, 2025 Direct
OCULAR THERAPEUTIX, INC Executive Chairman, President and CEO, Director Common Stock 300K $3.4M $11.34 Nov 26, 2025 By Pravin Dugel 2024 Irrevocable Trust
Aerpio Pharmaceuticals, Inc. Director Common Stock 12.6K $25.9K $2.06 Jun 30, 2021 Direct
OCULAR THERAPEUTIX, INC Executive Chairman, President and CEO, Director Common Stock 0 $0 $11.34 Nov 26, 2025 By spouse
OCULAR THERAPEUTIX, INC Executive Chairman, President and CEO, Director Performance Stock Option (Right to Buy) 2.75M Jun 11, 2025 Direct
IVERIC bio, Inc. President, Director Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. President, Director Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. President, Director Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Pravin Dugel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OCUL OCULAR THERAPEUTIX, INC Nov 24, 2025 3 -$235K 4 Nov 26, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Sep 9, 2025 2 $0 4 Sep 11, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Aug 25, 2025 1 -$259K 4 Aug 27, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Jun 11, 2025 1 $0 4 Jun 13, 2025 Executive Chairman, President and CEO. Exhibit 24 - Power of Attorney, Director
OCUL OCULAR THERAPEUTIX, INC May 23, 2025 1 -$152K 4 May 27, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Apr 28, 2025 3 $0 4 Aug 13, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Feb 24, 2025 1 -$148K 4 Feb 26, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Feb 11, 2025 2 $0 4 Feb 13, 2025 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Nov 25, 2024 1 -$186K 4 Nov 27, 2024 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Aug 23, 2024 1 -$188K 4 Aug 27, 2024 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC May 23, 2024 1 -$125K 4 May 28, 2024 Executive Chairman, President and CEO, Director
OCUL OCULAR THERAPEUTIX, INC Feb 22, 2024 2 $0 4 Feb 26, 2024 Executive Chairman, Director
OCUL OCULAR THERAPEUTIX, INC Feb 21, 2024 0 $0 3 Feb 26, 2024 Executive Chairman, Director
ISEE IVERIC bio, Inc. Jul 11, 2023 11 $0 4 Jul 13, 2023 President, Director
ISEE IVERIC bio, Inc. May 3, 2023 2 $0 4 May 11, 2023 President, Director
ISEE IVERIC bio, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 President, Director
ISEE IVERIC bio, Inc. Jan 2, 2023 2 $0 4 Jan 4, 2023 President, Director
ISEE IVERIC bio, Inc. Dec 20, 2022 2 $0 4 Dec 22, 2022 President
ISEE IVERIC bio, Inc. Dec 18, 2022 2 $0 4 Dec 20, 2022 President
ISEE IVERIC bio, Inc. Nov 17, 2022 2 $0 4 Nov 21, 2022 President
ISEE IVERIC bio, Inc. May 3, 2022 2 $0 4 May 5, 2022 President
ISEE IVERIC bio, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 President
ISEE IVERIC bio, Inc. Dec 18, 2021 2 $0 4 Dec 21, 2021 President
ISEE IVERIC bio, Inc. Dec 16, 2021 2 $0 4 Dec 20, 2021 President
ISEE IVERIC bio, Inc. Nov 11, 2021 2 $7K 4 Nov 15, 2021 President
AADI Aerpio Pharmaceuticals, Inc. Jun 30, 2021 1 $9.62K 4 Jul 2, 2021 Director